Bovine colostrum is a health food supplement which prevents NSAID induced gut damage
Open Access
- 1 May 1999
- Vol. 44 (5) , 653-658
- https://doi.org/10.1136/gut.44.5.653
Abstract
BACKGROUND Non-steroidal anti-inflammatory drugs (NSAIDs) are effective for arthritis but cause gastrointestinal injury. Bovine colostrum is a rich source of growth factors and is marketed as a health food supplement. AIMS To examine whether spray dried, defatted colostrum or milk preparations could reduce gastrointestinal injury caused by indomethacin. METHODS Effects of test solutions, administered orally, were examined using an indomethacin restraint rat model of gastric damage and an indomethacin mouse model of small intestinal injury. Effects on migration of the human colonic carcinoma cell line HT-29 and rat small intestinal cell line RIE-1 were assessed using a wounded monolayer assay system (used as an in vitro model of wound repair) and effects on proliferation determined using [3H]thymidine incorporation. RESULTS Pretreatment with 0.5 or 1 ml colostral preparation reduced gastric injury by 30% and 60% respectively in rats. A milk preparation was much less efficacious. Recombinant transforming growth factor β added at a dose similar to that found in the colostrum preparation (12.5 ng/rat), reduced injury by about 60%. Addition of colostrum to drinking water (10% vol/vol) prevented villus shortening in the mouse model of small intestinal injury. Addition of milk preparation was ineffective. Colostrum increased proliferation and cell migration of RIE-1 and HT-29 cells. These effects were mainly due to constituents of the colostrum with molecular weights greater than 30 kDa. CONCLUSIONS Bovine colostrum could provide a novel, inexpensive approach for the prevention and treatment of the injurious effects of NSAIDs on the gut and may also be of value for the treatment of other ulcerative conditions of the bowel.Keywords
This publication has 25 references indexed in Scilit:
- Transforming growth factor β in bovine milk: concentration, stability and molecular mass formsJournal of Endocrinology, 1996
- Safety of Meloxicam: A Global Analysis of Clinical TrialsRheumatology, 1996
- A Six-Month Double-Blind Trial to Compare the Efficacy and Safety of Meloxicam 7.5 mg Daily and Naproxen 750 mg Daily in Patients with Rheumatoid ArthritisRheumatology, 1996
- Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migrationGastroenterology, 1995
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: HOW DO THEY DAMAGE THE GUT?Rheumatology, 1994
- Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor βGastroenterology, 1993
- Effect of luminal growth factor preservation on intestinal growthThe Lancet, 1993
- Dose-Dependent Effects of Fentanyl on Indomethacin-Induced Gastric DamageDigestion, 1991
- Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.BMJ, 1985
- The serum‐free growth of cultured cells in bovine colostrum and in milk obtained later in the lactation periodJournal of Cellular Physiology, 1981